Clinical trials: Inhalation Anesthesia
- Condition Inhalation Anesthesia
- Funder type Industry (pharma, biotech, devices)
- Accepts healthy volunteers yes
Cough
A Study to Investigate the Safety, Tolerability and Pharmacokinetics of GSK2339345.
This is a study of the sodium channel inhibitor, GSK2339345. Cohort 1 will assess the safety, tolerability and PK of single ascending doses of GSK2339345 administered via an aqueous droplet inhaler in healthy subjects.
- Trial name
- NCT01587716
- Testing
- GSK2339345 (Inhaled) Single Dose, GSK2339345 (Inhaled) Repeat Dose
- Where
- United Kingdom
- Volunteers
- 36 people, healthy volunteers welcome
- Sponsor
- GlaxoSmithKline